drugset / Trial / NCT00365261
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the effectiveness of Lunesta on cancer patients who have received chemotherapy and who require patient controlled analgesia (PCA), specifically to assess whether Lunesta will: * improve sleep thereby decreasing need for opiates via PCA * improve sleep thereby decreasing pain by self report * improve sleep thereby decreasing fatigue by self report
Timeline
- Start
- 2006-09
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eszopiclone | Small molecule | 2 mg | — |
| Comparator | Eszopiclone | Small molecule | 3 mg | — |